A more recent work used 1D11 to demonstrate that aberrant activation of transforming growth factor-β (TGF-β) mobilizes mesenchymal/stromal stem cells in blood, which are recruited for the prostatic stromal hyperplasia (Wang et al., 2017). Here, TGFB1 is linked to hyperplasia.